Patients ’ Preferences for Systemic Lupus Erythematosus Treatments—A Discrete Choice Experiment

ConclusionsSLE patients fall into two groups with distinct preferences: benefit-seekers, who prioritize reducing the impact of disease symptoms, and risk-avoiders, who prioritize avoiding treatment risks. The implication of this finding will depend on the reasons for these differences, which warrant further research. Our study suggests that these differences arise due to the impact of disease and treatment experience on preferences. If so, well-informed patients may not be willing to tolerate the risks associated with oral corticosteroids in exchange for their benefits.
Source: The Patient - Patient-Centered Outcomes Research - Category: International Medicine & Public Health Source Type: research